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Abstract 
  BACKGROUND: Atherosclerosis, which is a result of gradual deposition of lipids in the lower 
part of blood vessel endothelium, is the leading cause of mortality and morbidity around the 
world. It has been proved that some inflammatory blood markers such as fibrinogen can predict 
the risk for cardiovascular disease conditions, not only in cardiovascular patients, but also in 
those who do not have any manifestations of the atherosclerotic development. In this study, the 
effect of cornus mas L. was evaluated on fibrinogen of hypercholesterolemic rabbits and it was 
also compared with lovastatin drug. 
  METHODS: In this study, 25 New Zealand adult male rabbits were randomly divided into five 
groups of five. They were treated for 60 days by 5 different diets, namely basic, high cholesterol, 
regular plus 1 g/kgBW cornus mas L. powder, high cholesterol plus 1 g/kgBW cornus mas L. 
powder, and high cholesterol plus 10 mg/kgBW lovastatin. At the beginning and at the end of 
this period, blood samples were collected from the rabbits and their serum fibrinogen levels 
were measured. 
  RESULTS: Cornus mas L. powder and lovastatin significantly decreased fibrinogen levels in 
comparison with high cholesterol group (P < 0.05). Furthermore cornus mas L. powder could 
reduce the fibrinogen level more than lovastatin (P < 0.05). 
  CONCLUSION: The results indicated that consumption of cornus mas L. might be beneficial in 
atherosclerotic patients due to its reducing effects on fibrinogen. 
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Introduction 
Iatrogenic  femoral  artery  pseudoaneurysm  (FAP) 
forms when an arterial puncture site fails to seal (ina-
bility to apply hemostasis) allowing blood to jet into 
the surrounding tissues and form a pulsatile hemato-
ma.  These  lesions  lack  a  fibrous  wall  and  are  con-
tained by a surrounding shell of hematoma and the 
overlying soft tissues. Pseudoaneurysms usually occur 
in low puncture situations, because there is suitable 
mass of soft tissue to contain the bleeding. In con-
trast, high puncture results in free hematoma due to 
lack of sufficient surrounding tissue. It can present as 
a new thrill or bruit, pulsatile hematoma, or marked 
pain  or  tenderness.  Complications  of  pseudoaneu-
rysms include rupture, distal embolization, local pain, 
neuropathy and local skin ischemia. Unlike FAPs of a 
surgical  or  post-traumatic  nature,  catheterization-
induced pseudoaneurysm has usually a benign natural 
history and 80% of cases resolve spontaneously. Sev-
eral  therapeutic  strategies  have  been  developed  to 
treat this condition. They include ultrasound-guided 
compression repair (UGCR), compression repair by 
mechanical  devices,  surgical  repair,  and  minimally 
invasive treatments (thrombin injection, coil emboli-
zation  and  insertion  of  covered  stents).  UGCR  of 
femoral artery pseudoaneurysm has become the first 
line treatment in many centers. The introduction of 
this procedure by Fellmeth in 1991 has reduced the 
need for surgical repair dramatically, and its cost is 
much lower than that of open and endovascular re-
pair.1 
UGCR Technique 
Ultrasound  probe  must  be  placed  on  the  neck  of 
pseudoaneurysm with the intention of complete obli-
teration of blood flow to the pseudoaneurysm. Some-
times,  if  the  neck  cannot  be  discerned  precisely  in 
ultrasonic  evaluation,  pressure  is  applied  non-
specifically on extraluminal lesion, but precise detec-
tion  of  pseudoaneurysm  neck  increases  procedural 
success. Pressure is applied for a period of at least 1 
minute, with the procedure repeated 10 times. At the   S. Asgary, M. Rafieian-Kopaei, A. Adelnia, S. Kazemi, F. Shamsi 
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end of each period, compression is relieved briefly to 
assess pseudoaneurysm patency and to reposition the 
transducer. Care must be practiced to avoid compro-
mising flow within the underlying femoral artery. Af-
ter successful thrombosis patients should lie supine 
for a few hours, with the affected leg in the stretched 
position.2-4  UGCR  has  considerable  drawbacks  in-
cluding long procedure time, discomfort to patients 
and  relatively  high  recurrence  rate  especially  in  pa-
tients  receiving  anticoagulant  therapy  (up  to  35%). 
Moreover, UGCR has been shown to be less effica-
cious in patients with large FAP (i.e., larger than 3 to 
4 cm in diameter), obese patients and those who can-
not tolerate the associated discomfort. The procedure 
carries an overall complication rate of 3.6% and risk 
of rupture of 1%. Complications include acute pseu-
doaneurysmal  enlargement,  rupture,  vasovagal  reac-
tions,  deep  vein  thrombosis,  atrial  fibrillation  and 
chest  discomfort.  Moreover,  UGCR  requires  the 
availability of an ultrasound device and the presence 
of skilled personnel during the procedure.2-4 
Compression on pseudoaneurysm of neck can 
be applied by mechanical devices like FemoS-
top. 
Compression Technique 
Pseudoaneurysm of neck must be viewed precisely by 
ultrasonography and its location should be marked on 
groin skin. Also, neck compressibility must be tested 
by ultrasound probe. Then, device should be fixed on 
the exact location and pressure applied for 20 minutes 
intervals and each time, FPA neck patency evaluated 
by ultrasonography. If the neck was still patent, the 
procedure must be repeated. Some authors reached 
results comparable to UGCR in terms of feasibility, 
safety and effectiveness and better results in terms of 
operator and patient comfort and cost.5 Recently, pa-
ra-aneurysmal saline injection has been advocated as a 
mean to treat FAP. It is a safe and effective technique 
comparable to UGCR. The procedure time is much 
lower in the latter and the patient is more comforta-
ble.6 
 
Saline Injection Technique 
Under sonographic guidance, 25-60 ml 0.9% normal 
saline must be injected in the tissues surrounding the 
tract connecting pseudoaneurysm to the femoral ar-
tery. Tract patency must be examined 24 hours later, 
sonographically.6 
  Thrombin injection is a more recent way to induce 
thrombosis  in  pseudoaneurysms.  Thrombin  is  the 
active  form  of  prothrombin.  Fortunately  thrombin 
that inadvertently leaks to the general circulation will 
rapidly diluted and antagonized by antithrombin and 
thrombomodulin.  
Thrombin Injection Technique 
An ultrasound examination is used to define the rela-
tionship of pseudoaneurysm of neck and native ves-
sels. The peripheral pulses are then documented. Un-
der sterile conditions, a 22-gauge spinal needle is in-
serted with ultrasound guidance into the periphery of 
the pseudoaneurysm. The needle tip should be placed 
as remote from the pseudoaneurysm neck as possible. 
Human  thrombin  at  strength  of  1000  units/mL 
should  be  injected  slowly  via  a  1  mL  syringe.  The 
pseudoaneurysm  is  scanned  continuously  and  injec-
tion terminated when color flow ceases (Figure 1).7 
 
 
Figure 1. Ultrasound-guided puncture of pseudoaneurysm. 
 
  In most cases, only 200 U (0.2 ml) thrombin is 
sufficient  to  induce  thrombosis  in  the  pseudoaneu-
rysm. Rarely and especially in multiloculated cases, it 
becomes necessary to repeat injections. If most of the 
pseudoaneurysm became thrombosed but the flow in 
pseudoaneurysm of neck did not cease, it is not ne-
cessary to repeat injection. This will raise the risk of 
distal embolization and in most cases, flow in pseu-
doaneurysm of neck will cease in the later stages. At 
the  end  of  procedure,  peripheral  pulses  must  be 
checked to exclude distal embolization. The patient 
must be in complete bed rest for 4 hours and scanned 
24 hours later to confirm flow cessation in pseudoa-
neurysm. In another technique, thrombin can be    O. Hashemi Fard 
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Table 1. Comparison of thrombin injection and UGCR in treatment of FAP. 
 
 
injected directly in the pseudoaneurysm under fluo-
roscopic guidance while it is filled by contrast from 
the contralateral site. It is recommended to inflate a 
balloon  catheter  near  pseudoaneurysm  of  neck  to 
prevent thrombin leakage.7-13 More recently, collagen 
preparation has been used instead of thrombin with 
comparable results. 
  Complications of thrombin injection are rare and 
can be divided into allergic10,11 and thrombotic reac-
tions.  While  human  thrombin  usage  has  minimized 
the  former,  thrombotic  accidents  remains  the  well-
known major complication. It occurs when large vo-
lume of thrombin is injected in a small pseudoaneu-
rysm with a wide neck. In this case, thrombin may 
resolve  spontaneously  or  may  require  intervention. 
Table 1 shows comparison of thrombin injection and 
UGCR in treatment of FAP.7,14 
Interventional techniques 
Coil and Onyx embolization and stent graft implanta-
tion are two ways of treating arterial pseudoaneurysm. 
Due to efficacy of previously mentioned procedures, 
these procedures are seldom required.15,16 
Coil Embolization Technique 
Coil packing can be done from ipsilateral groin and 
directly in the pseudoaneurysm and rarely from the 
contralateral  route  by  cross-over  technique.  In  the 
former, coils are released one by one through a cathe-
ter with its tip placed directly in the pseudoaneurysm 
under  fluoroscopic  guidance.  In  another  method, 
PDA coil was not released and remained attached to 
its  delivery  system,  while  thrombus  formation  was 
followed in the pseudoaneurysm. After pseudoaneu-
rysm became completely thrombosed, coil, its delivery 
system and catheter were withdrawn from pseudoa-
neurysm.15 
Surgical treatment 
It is beyond the scope of this article to discuss surgic-
al  techniques  of  pseudoaneurysm  repair.  But,  it  is 
worth to  mention that surgery  is  now  very seldom 
required  in  the  management  of  post-catheterization 
FAP with its benign course and multiple nonsurgical 
therapeutic  options.  It  must  be  reserved  for  large 
wide neck pseudoaneurysms which is often the result 
of trauma and surgery. Figure 2 depicts one treatment 
algorithm in the management of FAP.7 
 
 
Figure 2. Suggested treatment algorithm of FAP. 
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